Geriatrician survey: Swift telehealth adoption was ‘instrumental’ to pandemic patient care
By
Alicia Lasek
Mar 18, 2022
Responses by Genesis HealthCare physicians offer insight into the dramatic shift in care delivery that took place as COVID-19 raged in 2020.
Clinical briefs for Thursday, March 17
By
Alicia Lasek
Mar 17, 2022
FDA to host public workshop addressing gaps in opioid prescriber education content … Frailty in rheumatoid arthritis reversible with treatment and exercise … FDA approves Symbicort aerosol generic...
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
By
Alicia Lasek
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
Manageable risks for dementia and heart disease are closely linked, AHA’s annual report finds
By
Alicia Lasek
Jan 27, 2022
There is growing evidence that what is good for the heart is good for the brain. But that knowledge and awareness has not yet trickled down to patients, the authors say.
Environment may play a big role in Alzheimer’s risk, twins study finds
By
Alicia Lasek
Dec 21, 2021
The risk of developing Alzheimer’s-associated brain plaques is only partly due to heredity, a new study of twins finds. The results suggest a role for modifiable factors as well, according to investigators.
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...